查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1318013

疟疾疫苗市场：按类型、药物、最终用户划分 - 全球预测 2023-2030

Malaria Vaccine Market by Type, Agent, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球疟疾疫苗市场预计到2023年将达到6,434万美元，年复合成长率为25.77%，预计到2030年将出现惊人成长，达到3,2066万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球疟疾疫苗市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 疟疾疫苗的全球市场规模和预测是多少？

2.在预测期内，COVID-19 对全球疟疾疫苗市场的阻碍因素和影响为何？

3. 在预测期内，全球疟疾疫苗市场需要投资哪些产品/细分市场/应用/领域？

4.全球疟疾疫苗市场的竞争策略是什么？

5. 全球疟疾疫苗市场的技术趋势和法律规范是什么？

6. 全球疟疾疫苗市场主要供应商的市占率是多少？

7. 哪些型态和策略性措施被认为适合进入全球疟疾疫苗市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 增加常规免疫计划
      • 疟疾疫苗的供应、可近性的提高和政府的有利支持
      • 提高患者对疟疾的认识和发病率
    • 抑制因素
      • 疫苗很贵
    • 机会
      • 新佐剂的不断出现和突破性的疫苗传递方案
      • 製药业疫苗开发的进展
    • 任务
      • 严格法规场景
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章疟疾疫苗市场：依类型

  • 红血球疫苗
  • 多重抗原疫苗
  • 红血球前疫苗

第7章疟疾疫苗市场（依代理商）

  • 按蚊种
  • 恶性疟原虫
  • 间日疟原虫

第8章疟疾疫苗市场：依最终用户分类

  • 诊所
  • 社区中心
  • 医院

第9章美洲疟疾疫苗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区疟疾疫苗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲疟疾疫苗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-035DA3C63711

The Global Malaria Vaccine Market is forecasted to grow significantly, with a projected USD 64.34 million in 2023 at a CAGR of 25.77% and expected to reach a staggering USD 320.66 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Malaria Vaccine Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Malaria Vaccine Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Erythrocytic Vaccine, Multi-Antigen Vaccine, and Pre-Erythrocytic Vaccine. The Erythrocytic Vaccine is projected to witness significant market share during forecast period.

Based on Agent, market is studied across Anopheles Species, Plasmodium Falciparum, and Plasmodium Vivax. The Anopheles Species is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Clinics, Community Centers, and Hospitals. The Community Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Malaria Vaccine Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Malaria Vaccine Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Malaria Vaccine Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Malaria Vaccine Market?

4. What is the competitive strategic window for opportunities in the Global Malaria Vaccine Market?

5. What are the technology trends and regulatory frameworks in the Global Malaria Vaccine Market?

6. What is the market share of the leading vendors in the Global Malaria Vaccine Market?

7. What modes and strategic moves are considered suitable for entering the Global Malaria Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Malaria Vaccine Market, by Type, 2022 vs 2030
  • 4.3. Malaria Vaccine Market, by Agent, 2022 vs 2030
  • 4.4. Malaria Vaccine Market, by End-User, 2022 vs 2030
  • 4.5. Malaria Vaccine Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Proliferation in the number of routine immunizations programs
      • 5.1.1.2. Rising availability, accessibility and favorable government support for malaria vaccine
      • 5.1.1.3. Growing patient awareness and incidence of malaria
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advent of novel adjuvants and breakthrough vaccine delivery programs
      • 5.1.3.2. Rising advancements in pharmaceutical industry for vaccines
    • 5.1.4. Challenges
      • 5.1.4.1. Rigid regulative scenarios
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Malaria Vaccine Market, by Type

  • 6.1. Introduction
  • 6.2. Erythrocytic Vaccine
  • 6.3. Multi-Antigen Vaccine
  • 6.4. Pre-Erythrocytic Vaccine

7. Malaria Vaccine Market, by Agent

  • 7.1. Introduction
  • 7.2. Anopheles Species
  • 7.3. Plasmodium Falciparum
  • 7.4. Plasmodium Vivax

8. Malaria Vaccine Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinics
  • 8.3. Community Centers
  • 8.4. Hospitals

9. Americas Malaria Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Malaria Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Malaria Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. MALARIA VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. MALARIA VACCINE MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MALARIA VACCINE MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. MALARIA VACCINE MARKET SIZE, BY AGENT, 2022 VS 2030 (%)
  • FIGURE 6. MALARIA VACCINE MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. MALARIA VACCINE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. MALARIA VACCINE MARKET DYNAMICS
  • FIGURE 9. MALARIA VACCINE MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. MALARIA VACCINE MARKET SIZE, BY AGENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MALARIA VACCINE MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MALARIA VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MALARIA VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. MALARIA VACCINE MARKET SIZE, BY ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. MALARIA VACCINE MARKET SIZE, BY MULTI-ANTIGEN VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MALARIA VACCINE MARKET SIZE, BY PRE-ERYTHROCYTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 9. MALARIA VACCINE MARKET SIZE, BY ANOPHELES SPECIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MALARIA VACCINE MARKET SIZE, BY PLASMODIUM FALCIPARUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MALARIA VACCINE MARKET SIZE, BY PLASMODIUM VIVAX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. MALARIA VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MALARIA VACCINE MARKET SIZE, BY COMMUNITY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MALARIA VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES MALARIA VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY AGENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM MALARIA VACCINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. MALARIA VACCINE MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 144. MALARIA VACCINE MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 145. MALARIA VACCINE MARKET LICENSE & PRICING